Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 218

1.

Endpoints in preclinical Alzheimer's disease trials.

Reiman EM, Langbaum JB, Tariot PN.

J Clin Psychiatry. 2014 Jun;75(6):661-2. doi: 10.4088/JCP.14com09235. No abstract available.

PMID:
25004189
[PubMed - in process]
2.

Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis.

Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, Moreno S, Reiman EM, Ringman JM, Salloway S, Schofield PR, Sperling R, Tariot PN, Xiong C, Morris JC, Bateman RJ; Dominantly Inherited Alzheimer Network.

Neurology. 2014 Jul 15;83(3):253-60. doi: 10.1212/WNL.0000000000000596. Epub 2014 Jun 13.

PMID:
24928124
[PubMed - in process]
3.

The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.

Ayutyanont N, Langbaum JB, Hendrix SB, Chen K, Fleisher AS, Friesenhahn M, Ward M, Aguirre C, Acosta-Baena N, Madrigal L, Muñoz C, Tirado V, Moreno S, Tariot PN, Lopera F, Reiman EM.

J Clin Psychiatry. 2014 Jun;75(6):652-60. doi: 10.4088/JCP.13m08927.

PMID:
24816373
[PubMed - in process]
4.

An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.

Langbaum JB, Hendrix SB, Ayutyanont N, Chen K, Fleisher AS, Shah RC, Barnes LL, Bennett DA, Tariot PN, Reiman EM.

Alzheimers Dement. 2014 Apr 18. pii: S1552-5260(14)00063-6. doi: 10.1016/j.jalz.2014.02.002. [Epub ahead of print]

PMID:
24751827
[PubMed - as supplied by publisher]
5.

Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity.

Han P, Tang Z, Yin J, Maalouf M, Beach TG, Reiman EM, Shi J.

Neurobiol Aging. 2014 Sep;35(9):2064-71. doi: 10.1016/j.neurobiolaging.2014.03.022. Epub 2014 Mar 22.

PMID:
24726470
[PubMed - in process]
6.

Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer disease.

Han P, Liang W, Baxter LC, Yin J, Tang Z, Beach TG, Caselli RJ, Reiman EM, Shi J.

Neurology. 2014 May 13;82(19):1724-8. doi: 10.1212/WNL.0000000000000417. Epub 2014 Apr 9.

PMID:
24719484
[PubMed - indexed for MEDLINE]
7.

Association of amyloid burden, brain atrophy and memory deficits in aged apolipoprotein ε4 mice.

Yin J, Turner GH, Coons SW, Maalouf M, Reiman EM, Shi J.

Curr Alzheimer Res. 2014 Mar;11(3):283-90.

PMID:
24694076
[PubMed - in process]
8.

Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study.

Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ; AV45-A11 Study Group.

Mol Psychiatry. 2014 Mar 11. doi: 10.1038/mp.2014.9. [Epub ahead of print]

PMID:
24614494
[PubMed - as supplied by publisher]
9.

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Acta Neuropathol Commun. 2014 Mar 6;2(1):26. doi: 10.1186/2051-5960-2-26.

PMID:
24602322
[PubMed]
Free PMC Article
10.

Brain glucose and acetoacetate metabolism: a comparison of young and older adults.

Nugent S, Tremblay S, Chen KW, Ayutyanont N, Roontiva A, Castellano CA, Fortier M, Roy M, Courchesne-Loyer A, Bocti C, Lepage M, Turcotte E, Fulop T, Reiman EM, Cunnane SC.

Neurobiol Aging. 2014 Jun;35(6):1386-95. doi: 10.1016/j.neurobiolaging.2013.11.027. Epub 2013 Dec 1.

PMID:
24388785
[PubMed - in process]
11.

Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates.

Dugger BN, Clark CM, Serrano G, Mariner M, Bedell BJ, Coleman RE, Doraiswamy PM, Lu M, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, Schneider JA, Zehntner SP, Carpenter AP, Joshi AD, Mintun MA, Pontecorvo MJ, Skovronsky DM, Sue LI, Beach TG.

J Neuropathol Exp Neurol. 2014 Jan;73(1):72-80. doi: 10.1097/NEN.0000000000000028.

PMID:
24335535
[PubMed - indexed for MEDLINE]
12.

Alzheimer's disease and other dementias: advances in 2013.

Reiman EM.

Lancet Neurol. 2014 Jan;13(1):3-5. doi: 10.1016/S1474-4422(13)70257-6. Review. No abstract available.

PMID:
24331781
[PubMed - indexed for MEDLINE]
13.

Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.

Dean DC 3rd, Jerskey BA, Chen K, Protas H, Thiyyagura P, Roontiva A, O'Muircheartaigh J, Dirks H, Waskiewicz N, Lehman K, Siniard AL, Turk MN, Hua X, Madsen SK, Thompson PM, Fleisher AS, Huentelman MJ, Deoni SC, Reiman EM.

JAMA Neurol. 2014 Jan;71(1):11-22. doi: 10.1001/jamaneurol.2013.4544.

PMID:
24276092
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Clinical and multimodal biomarker correlates of ADNI neuropathological findings.

Toledo JB, Cairns NJ, Da X, Chen K, Carter D, Fleisher A, Householder E, Ayutyanont N, Roontiva A, Bauer RJ, Eisen P, Shaw LM, Davatzikos C, Weiner MW, Reiman EM, Morris JC, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Acta Neuropathol Commun. 2013 Oct 9;1(1):65. doi: 10.1186/2051-5960-1-65.

PMID:
24252435
[PubMed]
Free PMC Article
15.

Origin of the PSEN1 E280A mutation causing early-onset Alzheimer's disease.

Lalli MA, Cox HC, Arcila ML, Cadavid L, Moreno S, Garcia G, Madrigal L, Reiman EM, Arcos-Burgos M, Bedoya G, Brunkow ME, Glusman G, Roach JC, Hood L, Kosik KS, Lopera F.

Alzheimers Dement. 2013 Nov 13. pii: S1552-5260(13)02840-9. doi: 10.1016/j.jalz.2013.09.005. [Epub ahead of print]

PMID:
24239249
[PubMed - as supplied by publisher]
16.

Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers.

Adamczuk K, De Weer AS, Nelissen N, Chen K, Sleegers K, Bettens K, Van Broeckhoven C, Vandenbulcke M, Thiyyagura P, Dupont P, Van Laere K, Reiman EM, Vandenberghe R.

Neuroimage Clin. 2013 Apr 11;2:512-20. doi: 10.1016/j.nicl.2013.04.001. eCollection 2013.

PMID:
24179803
[PubMed]
Free PMC Article
17.

Overfeeding over 24 hours does not activate brown adipose tissue in humans.

Schlögl M, Piaggi P, Thiyyagura P, Reiman EM, Chen K, Lutrin C, Krakoff J, Thearle MS.

J Clin Endocrinol Metab. 2013 Dec;98(12):E1956-60. doi: 10.1210/jc.2013-2387. Epub 2013 Sep 30.

PMID:
24081739
[PubMed - indexed for MEDLINE]
18.

Apolipoprotein E as a β-amyloid-independent factor in Alzheimer's disease.

Wolf AB, Valla J, Bu G, Kim J, LaDu MJ, Reiman EM, Caselli RJ.

Alzheimers Res Ther. 2013 Sep 3;5(5):38. doi: 10.1186/alzrt204. eCollection 2013. Review.

PMID:
23998393
[PubMed]
Free PMC Article
19.

Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial.

Wang T, Huang Q, Reiman EM, Chen K, Li X, Li G, Lin Z, Li C, Xiao S.

J Clin Psychopharmacol. 2013 Oct;33(5):636-42. doi: 10.1097/JCP.0b013e31829a876a.

PMID:
23948786
[PubMed - indexed for MEDLINE]
20.

Imaging markers for Alzheimer disease: which vs how.

Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, Jack CR Jr, Jagust WJ, Johnson KA, Rowe CC, Sperling RA, Thies W, Wahlund LO, Weiner MW, Pasqualetti P, Decarli C; ISTAART's NeuroImaging Professional Interest Area.

Neurology. 2013 Jul 30;81(5):487-500. doi: 10.1212/WNL.0b013e31829d86e8. Review.

PMID:
23897875
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk